APO Research
Talk to an analyst

APO RESEARCH · REPORT

Genetically Modified Animal Models

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Genetically Modified Animal Models Market Analysis and Forecast 2026-2032

2 May 2026205 pages

Choose your research edition.

Industry ResearchGenetically Modified Animal Models Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Genetically Modified Animal Models Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Genetically Modified Animal Models Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genetically Modified Animal Models Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Genetically Modified Animal Models Market Analysis and Forecast 2026-2032205 pages · $4,950 USD

Market perspective

The global Genetically Modified Animal Models market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Genetically Modified Animal Models is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Genetically Modified Animal Models is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Genetically Modified Animal Models is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Genetically Modified Animal Models is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Genetically Modified Animal Models include ModelOrg, GemPharmatech, Cyagen Biosciences, Biocytogen, JOINN, China Environmental Technology and Bioenergy, Charles River, Taconic Biosciences and GenOway, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Genetically Modified Animal Models, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Genetically Modified Animal Models, also provides the revenue of main regions and countries. Of the upcoming market potential for Genetically Modified Animal Models, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Genetically Modified Animal Models revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Genetically Modified Animal Models market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Genetically Modified Animal Models revenue, projected growth trends, production technology, application and end-user industry.

Genetically Modified Animal Models Segment by Company

ModelOrg

GemPharmatech

Cyagen Biosciences

Biocytogen

JOINN

China Environmental Technology and Bioenergy

Charles River

Taconic Biosciences

GenOway

CLEA Japan

Ozgene

InVivo Biosystems

Harbour BioMed

PolyGene

Genetically Modified Animal Models Segment by Type

Rodents

Non-Human Primates

Zebrafish

Others

Genetically Modified Animal Models Segment by Application

Universities

Hospitals

Pharmaceutical Companies

Others

Genetically Modified Animal Models Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genetically Modified Animal Models market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genetically Modified Animal Models and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genetically Modified Animal Models.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Genetically Modified Animal Models in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Genetically Modified Animal Models company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Genetically Modified Animal Models revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Genetically Modified Animal Models Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Rodents Major Player Table 3. Non-Human Primates Major Player Table 4. Zebrafish Major Player Table 5. Others Major Player Table 6. Global Genetically Modified Animal Models Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Universities Major Player Table 8. Hospitals Major Player Table 9. Pharmaceutical Companies Major Player Table 10. Others Major Player Table 11. Genetically Modified Animal Models Industry Trends Table 12. Genetically Modified Animal Models Industry Drivers Table 13. Genetically Modified Animal Models Industry Opportunities and Challenges Table 14. Genetically Modified Animal Models Industry Restraints Table 15. Global Genetically Modified Animal Models Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Genetically Modified Animal Models Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Genetically Modified Animal Models Market Share by Region (2021-2026) Table 18. Global Genetically Modified Animal Models Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Genetically Modified Animal Models Market Share by Region (2027-2032) Table 20. Global Genetically Modified Animal Models Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Genetically Modified Animal Models Revenue Market Share by Players (2021-2026) Table 22. Global Genetically Modified Animal Models Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Genetically Modified Animal Models Key Players Headquarters & Area Served Table 24. Global Genetically Modified Animal Models Players, Product Type & Application Table 25. Global Genetically Modified Animal Models Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Genetically Modified Animal Models by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Genetically Modified Animal Models Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Genetically Modified Animal Models Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Genetically Modified Animal Models Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Genetically Modified Animal Models Revenue Market Share by Type (2021-2026) Table 32. Global Genetically Modified Animal Models Revenue Market Share by Type (2027-2032) Table 33. Global Genetically Modified Animal Models Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Genetically Modified Animal Models Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Genetically Modified Animal Models Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Genetically Modified Animal Models Revenue Market Share by Application (2021-2026) Table 37. Global Genetically Modified Animal Models Revenue Market Share by Application (2027-2032) Table 38. ModelOrg Company Information Table 39. ModelOrg Business Overview Table 40. ModelOrg Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. ModelOrg Genetically Modified Animal Models Product Portfolio Table 42. ModelOrg Recent Development Table 43. GemPharmatech Company Information Table 44. GemPharmatech Business Overview Table 45. GemPharmatech Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. GemPharmatech Genetically Modified Animal Models Product Portfolio Table 47. GemPharmatech Recent Development Table 48. Cyagen Biosciences Company Information Table 49. Cyagen Biosciences Business Overview Table 50. Cyagen Biosciences Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Cyagen Biosciences Genetically Modified Animal Models Product Portfolio Table 52. Cyagen Biosciences Recent Development Table 53. Biocytogen Company Information Table 54. Biocytogen Business Overview Table 55. Biocytogen Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Biocytogen Genetically Modified Animal Models Product Portfolio Table 57. Biocytogen Recent Development Table 58. JOINN Company Information Table 59. JOINN Business Overview Table 60. JOINN Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. JOINN Genetically Modified Animal Models Product Portfolio Table 62. JOINN Recent Development Table 63. China Environmental Technology and Bioenergy Company Information Table 64. China Environmental Technology and Bioenergy Business Overview Table 65. China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio Table 67. China Environmental Technology and Bioenergy Recent Development Table 68. Charles River Company Information Table 69. Charles River Business Overview Table 70. Charles River Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Charles River Genetically Modified Animal Models Product Portfolio Table 72. Charles River Recent Development Table 73. Taconic Biosciences Company Information Table 74. Taconic Biosciences Business Overview Table 75. Taconic Biosciences Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. Taconic Biosciences Genetically Modified Animal Models Product Portfolio Table 77. Taconic Biosciences Recent Development Table 78. GenOway Company Information Table 79. GenOway Business Overview Table 80. GenOway Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. GenOway Genetically Modified Animal Models Product Portfolio Table 82. GenOway Recent Development Table 83. CLEA Japan Company Information Table 84. CLEA Japan Business Overview Table 85. CLEA Japan Genetically Modified Animal Models Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. CLEA Japan Genetically Modified Animal Models Product Portfolio Table 87. CLEA Japan Recent Development Table 88. Ozgene Company Information Table 89. Ozgene Business Overview Table 90. Ozgene Genetically Modified Animal Models Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Ozgene Genetically Modified Animal Models Product Portfolio Table 92. Ozgene Recent Development Table 93. InVivo Biosystems Company Information Table 94. InVivo Biosystems Business Overview Table 95. InVivo Biosystems Genetically Modified Animal Models Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. InVivo Biosystems Genetically Modified Animal Models Product Portfolio Table 97. InVivo Biosystems Recent Development Table 98. Harbour BioMed Company Information Table 99. Harbour BioMed Business Overview Table 100. Harbour BioMed Genetically Modified Animal Models Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Harbour BioMed Genetically Modified Animal Models Product Portfolio Table 102. Harbour BioMed Recent Development Table 103. PolyGene Company Information Table 104. PolyGene Business Overview Table 105. PolyGene Genetically Modified Animal Models Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. PolyGene Genetically Modified Animal Models Product Portfolio Table 107. PolyGene Recent Development Table 108. North America Genetically Modified Animal Models Revenue by Type (2021-2026) & (US$ Million) Table 109. North America Genetically Modified Animal Models Revenue by Type (2027-2032) & (US$ Million) Table 110. North America Genetically Modified Animal Models Revenue by Application (2021-2026) & (US$ Million) Table 111. North America Genetically Modified Animal Models Revenue by Application (2027-2032) & (US$ Million) Table 112. North America Genetically Modified Animal Models Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 113. North America Genetically Modified Animal Models Revenue by Country (2021-2026) & (US$ Million) Table 114. North America Genetically Modified Animal Models Revenue by Country (US$ Million) & (2027-2032) Table 115. Europe Genetically Modified Animal Models Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Genetically Modified Animal Models Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Genetically Modified Animal Models Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Genetically Modified Animal Models Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Genetically Modified Animal Models Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. Europe Genetically Modified Animal Models Revenue by Country (2021-2026) & (US$ Million) Table 121. Europe Genetically Modified Animal Models Revenue by Country (US$ Million) & (2027-2032) Table 122. China Genetically Modified Animal Models Revenue by Type (2021-2026) & (US$ Million) Table 123. China Genetically Modified Animal Models Revenue by Type (2027-2032) & (US$ Million) Table 124. China Genetically Modified Animal Models Revenue by Application (2021-2026) & (US$ Million) Table 125. China Genetically Modified Animal Models Revenue by Application (2027-2032) & (US$ Million) Table 126. Asia Genetically Modified Animal Models Revenue by Type (2021-2026) & (US$ Million) Table 127. Asia Genetically Modified Animal Models Revenue by Type (2027-2032) & (US$ Million) Table 128. Asia Genetically Modified Animal Models Revenue by Application (2021-2026) & (US$ Million) Table 129. Asia Genetically Modified Animal Models Revenue by Application (2027-2032) & (US$ Million) Table 130. Asia Genetically Modified Animal Models Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Asia Genetically Modified Animal Models Revenue by Region (US$ Million) & (2021-2026) Table 132. Asia Genetically Modified Animal Models Revenue by Region (US$ Million) & (2027-2032) Table 133. SAMEA Genetically Modified Animal Models Revenue by Type (2021-2026) & (US$ Million) Table 134. SAMEA Genetically Modified Animal Models Revenue by Type (2027-2032) & (US$ Million) Table 135. SAMEA Genetically Modified Animal Models Revenue by Application (2021-2026) & (US$ Million) Table 136. SAMEA Genetically Modified Animal Models Revenue by Application (2027-2032) & (US$ Million) Table 137. SAMEA Genetically Modified Animal Models Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 138. SAMEA Genetically Modified Animal Models Revenue by Country (2021-2026) & (US$ Million) Table 139. SAMEA Genetically Modified Animal Models Revenue by Country (US$ Million) & (2027-2032) Table 140. Research Programs/Design for This Report Table 141. Authors List of This Report Table 142. Secondary Sources Table 143. Primary Sources List of Figures Figure 1. Genetically Modified Animal Models Image Figure 2. Global Genetically Modified Animal Models Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genetically Modified Animal Models Market Size Share 2021 VS 2025 VS 2032 Figure 4. Rodents Image Figure 5. Non-Human Primates Image Figure 6. Zebrafish Image Figure 7. Others Image Figure 8. Global Genetically Modified Animal Models Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Genetically Modified Animal Models Market Size Share 2021 VS 2025 VS 2032 Figure 10. Universities Image Figure 11. Hospitals Image Figure 12. Pharmaceutical Companies Image Figure 13. Others Image Figure 14. Global Genetically Modified Animal Models Market Size (US$ Million) & (2021-2032) Figure 15. Global Genetically Modified Animal Models Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Genetically Modified Animal Models Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Genetically Modified Animal Models Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Genetically Modified Animal Models Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Genetically Modified Animal Models Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Genetically Modified Animal Models Revenue Market Share by Type (2021-2032) Figure 22. Global Genetically Modified Animal Models Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Genetically Modified Animal Models Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Genetically Modified Animal Models Revenue Market Share by Application (2021-2032) Figure 25. North America Genetically Modified Animal Models Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Genetically Modified Animal Models Revenue Share by Type (2021-2032) Figure 27. North America Genetically Modified Animal Models Revenue Share by Application (2021-2032) Figure 28. North America Genetically Modified Animal Models Revenue Share by Country (2021-2032) Figure 29. United States Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Genetically Modified Animal Models Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Genetically Modified Animal Models Revenue Share by Type (2021-2032) Figure 34. Europe Genetically Modified Animal Models Revenue Share by Application (2021-2032) Figure 35. Europe Genetically Modified Animal Models Revenue Share by Country (2021-2032) Figure 36. Germany Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Genetically Modified Animal Models Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Genetically Modified Animal Models Revenue Share by Type (2021-2032) Figure 46. China Genetically Modified Animal Models Revenue Share by Application (2021-2032) Figure 47. Asia Genetically Modified Animal Models Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Genetically Modified Animal Models Revenue Share by Type (2021-2032) Figure 49. Asia Genetically Modified Animal Models Revenue Share by Application (2021-2032) Figure 50. Asia Genetically Modified Animal Models Revenue Share by Region (2021-2032) Figure 51. Japan Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Genetically Modified Animal Models Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Genetically Modified Animal Models Revenue Share by Type (2021-2032) Figure 59. SAMEA Genetically Modified Animal Models Revenue Share by Application (2021-2032) Figure 60. SAMEA Genetically Modified Animal Models Revenue Share by Country (2021-2032) Figure 61. Brazil Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Genetically Modified Animal Models Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Rodents
  • Non-Human Primates
  • Zebrafish
  • Others
Applications
  • Universities
  • Hospitals
  • Pharmaceutical Companies
  • Others
Companies covered
  • ModelOrg
  • GemPharmatech
  • Cyagen Biosciences
  • Biocytogen
  • JOINN
  • China Environmental Technology and Bioenergy
  • Charles River
  • Taconic Biosciences
  • GenOway
  • CLEA Japan
  • Ozgene
  • InVivo Biosystems
  • Harbour BioMed
  • PolyGene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Genetically Modified Animal Models Market by Type
  3. 1.2.1 Global Genetically Modified Animal Models Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Rodents
  5. 1.2.3 Non-Human Primates
  6. 1.2.4 Zebrafish
  7. 1.2.5 Others
  8. 1.3 Genetically Modified Animal Models Market by Application
  9. 1.3.1 Global Genetically Modified Animal Models Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Universities
  11. 1.3.3 Hospitals
  12. 1.3.4 Pharmaceutical Companies
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Genetically Modified Animal Models Market Dynamics
  1. 2.1 Genetically Modified Animal Models Industry Trends
  2. 2.2 Genetically Modified Animal Models Industry Drivers
  3. 2.3 Genetically Modified Animal Models Industry Opportunities and Challenges
  4. 2.4 Genetically Modified Animal Models Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Genetically Modified Animal Models Market Perspective (2021-2032)
  2. 3.2 Global Genetically Modified Animal Models Growth Trends by Region
  3. 3.2.1 Global Genetically Modified Animal Models Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Genetically Modified Animal Models Market Size by Region (2021-2026)
  5. 3.2.3 Global Genetically Modified Animal Models Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Genetically Modified Animal Models Revenue by Players
  2. 4.1.1 Global Genetically Modified Animal Models Revenue by Players (2021-2026)
  3. 4.1.2 Global Genetically Modified Animal Models Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Genetically Modified Animal Models Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Genetically Modified Animal Models Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Genetically Modified Animal Models Key Players Headquarters & Area Served
  7. 4.4 Global Genetically Modified Animal Models Players, Product Type & Application
  8. 4.5 Global Genetically Modified Animal Models Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Genetically Modified Animal Models Market CR5 and HHI
  11. 4.6.3 2025 Genetically Modified Animal Models Tier 1, Tier 2, and Tier 3
5 Genetically Modified Animal Models Market Size by Type
  1. 5.1 Global Genetically Modified Animal Models Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Genetically Modified Animal Models Revenue by Type (2021-2032)
  3. 5.3 Global Genetically Modified Animal Models Revenue Market Share by Type (2021-2032)
6 Genetically Modified Animal Models Market Size by Application
  1. 6.1 Global Genetically Modified Animal Models Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Genetically Modified Animal Models Revenue by Application (2021-2032)
  3. 6.3 Global Genetically Modified Animal Models Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 ModelOrg
  2. 7.1.1 ModelOrg Company Information
  3. 7.1.2 ModelOrg Business Overview
  4. 7.1.3 ModelOrg Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  5. 7.1.4 ModelOrg Genetically Modified Animal Models Product Portfolio
  6. 7.1.5 ModelOrg Recent Developments
  7. 7.2 GemPharmatech
  8. 7.2.1 GemPharmatech Company Information
  9. 7.2.2 GemPharmatech Business Overview
  10. 7.2.3 GemPharmatech Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  11. 7.2.4 GemPharmatech Genetically Modified Animal Models Product Portfolio
  12. 7.2.5 GemPharmatech Recent Developments
  13. 7.3 Cyagen Biosciences
  14. 7.3.1 Cyagen Biosciences Company Information
  15. 7.3.2 Cyagen Biosciences Business Overview
  16. 7.3.3 Cyagen Biosciences Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Cyagen Biosciences Genetically Modified Animal Models Product Portfolio
  18. 7.3.5 Cyagen Biosciences Recent Developments
  19. 7.4 Biocytogen
  20. 7.4.1 Biocytogen Company Information
  21. 7.4.2 Biocytogen Business Overview
  22. 7.4.3 Biocytogen Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Biocytogen Genetically Modified Animal Models Product Portfolio
  24. 7.4.5 Biocytogen Recent Developments
  25. 7.5 JOINN
  26. 7.5.1 JOINN Company Information
  27. 7.5.2 JOINN Business Overview
  28. 7.5.3 JOINN Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  29. 7.5.4 JOINN Genetically Modified Animal Models Product Portfolio
  30. 7.5.5 JOINN Recent Developments
  31. 7.6 China Environmental Technology and Bioenergy
  32. 7.6.1 China Environmental Technology and Bioenergy Company Information
  33. 7.6.2 China Environmental Technology and Bioenergy Business Overview
  34. 7.6.3 China Environmental Technology and Bioenergy Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  35. 7.6.4 China Environmental Technology and Bioenergy Genetically Modified Animal Models Product Portfolio
  36. 7.6.5 China Environmental Technology and Bioenergy Recent Developments
  37. 7.7 Charles River
  38. 7.7.1 Charles River Company Information
  39. 7.7.2 Charles River Business Overview
  40. 7.7.3 Charles River Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Charles River Genetically Modified Animal Models Product Portfolio
  42. 7.7.5 Charles River Recent Developments
  43. 7.8 Taconic Biosciences
  44. 7.8.1 Taconic Biosciences Company Information
  45. 7.8.2 Taconic Biosciences Business Overview
  46. 7.8.3 Taconic Biosciences Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Taconic Biosciences Genetically Modified Animal Models Product Portfolio
  48. 7.8.5 Taconic Biosciences Recent Developments
  49. 7.9 GenOway
  50. 7.9.1 GenOway Company Information
  51. 7.9.2 GenOway Business Overview
  52. 7.9.3 GenOway Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  53. 7.9.4 GenOway Genetically Modified Animal Models Product Portfolio
  54. 7.9.5 GenOway Recent Developments
  55. 7.10 CLEA Japan
  56. 7.10.1 CLEA Japan Company Information
  57. 7.10.2 CLEA Japan Business Overview
  58. 7.10.3 CLEA Japan Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  59. 7.10.4 CLEA Japan Genetically Modified Animal Models Product Portfolio
  60. 7.10.5 CLEA Japan Recent Developments
  61. 7.11 Ozgene
  62. 7.11.1 Ozgene Company Information
  63. 7.11.2 Ozgene Business Overview
  64. 7.11.3 Ozgene Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Ozgene Genetically Modified Animal Models Product Portfolio
  66. 7.11.5 Ozgene Recent Developments
  67. 7.12 InVivo Biosystems
  68. 7.12.1 InVivo Biosystems Company Information
  69. 7.12.2 InVivo Biosystems Business Overview
  70. 7.12.3 InVivo Biosystems Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  71. 7.12.4 InVivo Biosystems Genetically Modified Animal Models Product Portfolio
  72. 7.12.5 InVivo Biosystems Recent Developments
  73. 7.13 Harbour BioMed
  74. 7.13.1 Harbour BioMed Company Information
  75. 7.13.2 Harbour BioMed Business Overview
  76. 7.13.3 Harbour BioMed Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Harbour BioMed Genetically Modified Animal Models Product Portfolio
  78. 7.13.5 Harbour BioMed Recent Developments
  79. 7.14 PolyGene
  80. 7.14.1 PolyGene Company Information
  81. 7.14.2 PolyGene Business Overview
  82. 7.14.3 PolyGene Genetically Modified Animal Models Revenue and Gross Margin (2021-2026)
  83. 7.14.4 PolyGene Genetically Modified Animal Models Product Portfolio
  84. 7.14.5 PolyGene Recent Developments
8 North America
  1. 8.1 North America Genetically Modified Animal Models Revenue (2021-2032)
  2. 8.2 North America Genetically Modified Animal Models Revenue by Type (2021-2032)
  3. 8.2.1 North America Genetically Modified Animal Models Revenue by Type (2021-2026)
  4. 8.2.2 North America Genetically Modified Animal Models Revenue by Type (2027-2032)
  5. 8.3 North America Genetically Modified Animal Models Revenue Share by Type (2021-2032)
  6. 8.4 North America Genetically Modified Animal Models Revenue by Application (2021-2032)
  7. 8.4.1 North America Genetically Modified Animal Models Revenue by Application (2021-2026)
  8. 8.4.2 North America Genetically Modified Animal Models Revenue by Application (2027-2032)
  9. 8.5 North America Genetically Modified Animal Models Revenue Share by Application (2021-2032)
  10. 8.6 North America Genetically Modified Animal Models Revenue by Country
  11. 8.6.1 North America Genetically Modified Animal Models Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Genetically Modified Animal Models Revenue by Country (2021-2026)
  13. 8.6.3 North America Genetically Modified Animal Models Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Genetically Modified Animal Models Revenue (2021-2032)
  2. 9.2 Europe Genetically Modified Animal Models Revenue by Type (2021-2032)
  3. 9.2.1 Europe Genetically Modified Animal Models Revenue by Type (2021-2026)
  4. 9.2.2 Europe Genetically Modified Animal Models Revenue by Type (2027-2032)
  5. 9.3 Europe Genetically Modified Animal Models Revenue Share by Type (2021-2032)
  6. 9.4 Europe Genetically Modified Animal Models Revenue by Application (2021-2032)
  7. 9.4.1 Europe Genetically Modified Animal Models Revenue by Application (2021-2026)
  8. 9.4.2 Europe Genetically Modified Animal Models Revenue by Application (2027-2032)
  9. 9.5 Europe Genetically Modified Animal Models Revenue Share by Application (2021-2032)
  10. 9.6 Europe Genetically Modified Animal Models Revenue by Country
  11. 9.6.1 Europe Genetically Modified Animal Models Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Genetically Modified Animal Models Revenue by Country (2021-2026)
  13. 9.6.3 Europe Genetically Modified Animal Models Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Genetically Modified Animal Models Revenue (2021-2032)
  2. 10.2 China Genetically Modified Animal Models Revenue by Type (2021-2032)
  3. 10.2.1 China Genetically Modified Animal Models Revenue by Type (2021-2026)
  4. 10.2.2 China Genetically Modified Animal Models Revenue by Type (2027-2032)
  5. 10.3 China Genetically Modified Animal Models Revenue Share by Type (2021-2032)
  6. 10.4 China Genetically Modified Animal Models Revenue by Application (2021-2032)
  7. 10.4.1 China Genetically Modified Animal Models Revenue by Application (2021-2026)
  8. 10.4.2 China Genetically Modified Animal Models Revenue by Application (2027-2032)
  9. 10.5 China Genetically Modified Animal Models Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Genetically Modified Animal Models Revenue (2021-2032)
  2. 11.2 Asia Genetically Modified Animal Models Revenue by Type (2021-2032)
  3. 11.2.1 Asia Genetically Modified Animal Models Revenue by Type (2021-2026)
  4. 11.2.2 Asia Genetically Modified Animal Models Revenue by Type (2027-2032)
  5. 11.3 Asia Genetically Modified Animal Models Revenue Share by Type (2021-2032)
  6. 11.4 Asia Genetically Modified Animal Models Revenue by Application (2021-2032)
  7. 11.4.1 Asia Genetically Modified Animal Models Revenue by Application (2021-2026)
  8. 11.4.2 Asia Genetically Modified Animal Models Revenue by Application (2027-2032)
  9. 11.5 Asia Genetically Modified Animal Models Revenue Share by Application (2021-2032)
  10. 11.6 Asia Genetically Modified Animal Models Revenue by Country
  11. 11.6.1 Asia Genetically Modified Animal Models Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Genetically Modified Animal Models Revenue by Country (2021-2026)
  13. 11.6.3 Asia Genetically Modified Animal Models Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Genetically Modified Animal Models Revenue (2021-2032)
  2. 12.2 SAMEA Genetically Modified Animal Models Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Genetically Modified Animal Models Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Genetically Modified Animal Models Revenue by Type (2027-2032)
  5. 12.3 SAMEA Genetically Modified Animal Models Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Genetically Modified Animal Models Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Genetically Modified Animal Models Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Genetically Modified Animal Models Revenue by Application (2027-2032)
  9. 12.5 SAMEA Genetically Modified Animal Models Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Genetically Modified Animal Models Revenue by Country
  11. 12.6.1 SAMEA Genetically Modified Animal Models Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Genetically Modified Animal Models Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Genetically Modified Animal Models Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst